Granules India Limited (GRANULES.NS)
INR 451.3
(4.69%)
INR 451.3
(4.69%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 16.79 Billion INR | -23.8% |
| 2022 | 22.04 Billion INR | 24.68% |
| 2021 | 17.68 Billion INR | 1.56% |
| 2020 | 17.41 Billion INR | 41.58% |
| 2019 | 12.29 Billion INR | 29.57% |
| 2018 | 9.49 Billion INR | 33.8% |
| 2017 | 7.09 Billion INR | 0.31% |
| 2016 | 7.07 Billion INR | 24.31% |
| 2015 | 5.68 Billion INR | 24.4% |
| 2014 | 4.57 Billion INR | 19.2% |
| 2013 | 3.83 Billion INR | 32.14% |
| 2012 | 2.9 Billion INR | 21.16% |
| 2011 | 2.39 Billion INR | 179.63% |
| 2010 | 856.83 Million INR | -4.46% |
| 2009 | 896.81 Million INR | 0.0% |
| 2008 | - INR | -100.0% |
| 2007 | 520.14 Million INR | 29.87% |
| 2006 | 400.5 Million INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 4.78 Billion INR | -4.46% |
| 2023 Q2 | 6.14 Billion INR | 21.34% |
| 2023 FY | 16.79 Billion INR | -23.8% |
| 2023 Q1 | 5.06 Billion INR | -11.49% |
| 2023 Q4 | 5.01 Billion INR | -23.84% |
| 2023 Q3 | 6.58 Billion INR | 7.14% |
| 2022 Q2 | 5.72 Billion INR | 13.09% |
| 2022 FY | 22.04 Billion INR | 24.68% |
| 2022 Q4 | 5.72 Billion INR | 3.18% |
| 2022 Q3 | 5.54 Billion INR | -3.12% |
| 2022 Q1 | 5.06 Billion INR | 29.44% |
| 2021 Q1 | 4.6 Billion INR | 30.71% |
| 2021 FY | 17.68 Billion INR | 1.56% |
| 2021 Q3 | 4.64 Billion INR | 2.9% |
| 2021 Q2 | 4.51 Billion INR | -1.96% |
| 2021 Q4 | 3.9 Billion INR | -15.91% |
| 2020 Q2 | 4.97 Billion INR | 13.47% |
| 2020 Q1 | 4.38 Billion INR | 88.14% |
| 2020 Q4 | 3.52 Billion INR | -22.27% |
| 2020 Q3 | 4.53 Billion INR | -8.75% |
| 2020 FY | 17.41 Billion INR | 41.58% |
| 2019 Q1 | 2.99 Billion INR | 44.71% |
| 2019 FY | 12.29 Billion INR | 29.57% |
| 2019 Q2 | 3.4 Billion INR | 13.45% |
| 2019 Q3 | 3.56 Billion INR | 4.93% |
| 2019 Q4 | 2.32 Billion INR | -34.77% |
| 2018 Q3 | 2.72 Billion INR | 3.6% |
| 2018 Q2 | 2.63 Billion INR | 27.68% |
| 2018 FY | 9.49 Billion INR | 33.8% |
| 2018 Q1 | 2.06 Billion INR | 6.19% |
| 2018 Q4 | 2.07 Billion INR | -24.0% |
| 2017 Q4 | 1.94 Billion INR | -3.82% |
| 2017 Q3 | 2.01 Billion INR | 3.56% |
| 2017 Q2 | 1.94 Billion INR | -1.96% |
| 2017 FY | 7.09 Billion INR | 0.31% |
| 2017 Q1 | 1.98 Billion INR | -3.51% |
| 2016 FY | 7.07 Billion INR | 24.31% |
| 2016 Q2 | 1.5 Billion INR | 2.97% |
| 2016 Q4 | 2.05 Billion INR | 27.37% |
| 2016 Q1 | 1.46 Billion INR | -17.8% |
| 2016 Q3 | 1.61 Billion INR | 7.42% |
| 2015 Q4 | 1.77 Billion INR | 25.08% |
| 2015 FY | 5.68 Billion INR | 24.4% |
| 2015 Q3 | 1.42 Billion INR | 1.03% |
| 2015 Q2 | 1.4 Billion INR | 5.94% |
| 2015 Q1 | 1.32 Billion INR | 17.75% |
| 2014 Q1 | 1.1 Billion INR | 2.68% |
| 2014 Q2 | 1.15 Billion INR | 4.05% |
| 2014 Q3 | 1.18 Billion INR | 3.28% |
| 2014 Q4 | 1.12 Billion INR | -5.03% |
| 2014 FY | 4.57 Billion INR | 19.2% |
| 2013 Q2 | 942.57 Million INR | 22.93% |
| 2013 Q1 | 766.78 Million INR | -49.93% |
| 2013 FY | 3.83 Billion INR | 32.14% |
| 2013 Q4 | 1.07 Billion INR | 2.55% |
| 2013 Q3 | 1.04 Billion INR | 11.39% |
| 2012 Q3 | 453.92 Million INR | -7.2% |
| 2012 Q4 | 1.53 Billion INR | 237.35% |
| 2012 Q1 | 428.61 Million INR | 0.0% |
| 2012 FY | 2.9 Billion INR | 21.16% |
| 2012 Q2 | 489.14 Million INR | 14.12% |
| 2011 FY | 2.39 Billion INR | 179.63% |
| 2010 FY | 856.83 Million INR | -4.46% |
| 2009 FY | 896.81 Million INR | 0.0% |
| 2008 FY | - INR | -100.0% |
| 2007 FY | 520.14 Million INR | 29.87% |
| 2006 FY | 400.5 Million INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 26.78 Billion INR | 37.271% |
| Hester Biosciences Limited | 1.27 Billion INR | -1218.987% |
| Aarti Drugs Limited | 8.31 Billion INR | -102.007% |
| Aarti Pharmalabs Limited | 5.83 Billion INR | -188.086% |
| Albert David Limited | 1.4 Billion INR | -1093.057% |
| Alembic Limited | 1 Billion INR | -1579.748% |
| Alkem Laboratories Limited | 52.29 Billion INR | 67.877% |
| Bafna Pharmaceuticals Limited | 452.15 Million INR | -3615.397% |
| Bajaj HealthCare Limited | 1.47 Billion INR | -1041.406% |
| Biofil Chemicals and Pharmaceuticals Limited | 12.54 Million INR | -133812.156% |
| Brooks Laboratories Limited | 65.62 Million INR | -25500.853% |
| Eris Lifesciences Limited | 10.42 Billion INR | -61.117% |
| FDC Limited | 6.58 Billion INR | -155.067% |
| Glenmark Life Sciences Limited | 12.43 Billion INR | -35.119% |
| Gufic Biosciences Limited | 4.07 Billion INR | -312.38% |
| Hikal Limited | 5.95 Billion INR | -181.962% |
| Ind-Swift Limited | 2.17 Billion INR | -673.258% |
| Innova Captab Limited | 3.46 Billion INR | -384.906% |
| IOL Chemicals and Pharmaceuticals Limited | 4.71 Billion INR | -255.985% |
| Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | -2474.247% |
| Jubilant Pharmova Limited | 19.64 Billion INR | 14.477% |
| Lincoln Pharmaceuticals Limited | 1.88 Billion INR | -790.327% |
| Lupin Limited | 125.09 Billion INR | 86.571% |
| Mangalam Drugs & Organics Limited | 691.19 Million INR | -2330.476% |
| Medico Remedies Limited | 262.14 Million INR | -6308.417% |
| Morepen Laboratories Limited | 6.16 Billion INR | -172.659% |
| Nectar Lifesciences Limited | 4.82 Billion INR | -248.295% |
| Orchid Pharma Limited | 2.32 Billion INR | -624.012% |
| Procter & Gamble Health Limited | 5.78 Billion INR | -190.575% |
| RPG Life Sciences Limited | 2.48 Billion INR | -576.572% |
| Kilitch Drugs (India) Limited | 620.47 Million INR | -2607.478% |
| Sigachi Industries Limited | 2 Billion INR | -739.006% |
| Solara Active Pharma Sciences Limited | -1.65 Billion INR | 1114.511% |
| Suven Pharmaceuticals Limited | 4.12 Billion INR | -307.426% |
| Themis Medicare Limited | 2.42 Billion INR | -594.183% |
| Unichem Laboratories Limited | 4.86 Billion INR | -245.314% |
| Vaishali Pharma Limited | 90.32 Million INR | -18499.117% |
| Wanbury Limited | 1.73 Billion INR | -870.696% |
| Windlas Biotech Limited | 1.33 Billion INR | -1154.801% |
| ZIM Laboratories Limited | 1.26 Billion INR | -1225.06% |
| Ind-Swift Laboratories Limited | 4.13 Billion INR | -306.446% |
| Ipca Laboratories Limited | 48.58 Billion INR | 65.422% |
| Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 93.501% |
| Venus Remedies Limited | 2.18 Billion INR | -669.696% |
| Sakar Healthcare Limited | 699.58 Million INR | -2301.321% |
| Aurobindo Pharma Limited | 109.54 Billion INR | 84.664% |
| Divi's Laboratories Limited | 32.44 Billion INR | 48.214% |
| AstraZeneca Pharma India Limited | 6.22 Billion INR | -169.968% |
| Mankind Pharma Limited | 42.19 Billion INR | 60.188% |
| Sequent Scientific Limited | 2.97 Billion INR | -463.975% |
| Laurus Labs Limited | 15.44 Billion INR | -8.742% |
| Neuland Laboratories Limited | 8.24 Billion INR | -103.681% |
| J. B. Chemicals & Pharmaceuticals Limited | 15.25 Billion INR | -10.095% |
| Glenmark Pharmaceuticals Limited | 69.34 Billion INR | 75.773% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 86.583% |
| Amrutanjan Health Care Limited | 2.09 Billion INR | -702.244% |
| Wockhardt Limited | 7.72 Billion INR | -117.607% |
| Bal Pharma Limited | 770.19 Million INR | -2081.172% |
| Dr. Reddy's Laboratories Limited | 163.6 Billion INR | 89.732% |
| Bliss GVS Pharma Limited | 3.69 Billion INR | -354.595% |
| Par Drugs and Chemicals Limited | 529.13 Million INR | -3074.851% |
| Caplin Point Laboratories Limited | 9.2 Billion INR | -82.472% |
| Shilpa Medicare Limited | 3.56 Billion INR | -371.639% |
| Valiant Laboratories Limited | 138.02 Million INR | -12070.834% |
| Ajanta Pharma Limited | 21.06 Billion INR | 20.246% |
| Aarey Drugs & Pharmaceuticals Limited | 113.02 Million INR | -14762.805% |
| Medicamen Biotech Limited | 495.49 Million INR | -3290.404% |
| Syncom Formulations (India) Limited | 559.5 Million INR | -2902.536% |
| Piramal Enterprises Limited | 8.04 Billion INR | -108.861% |
| Torrent Pharmaceuticals Limited | 46.75 Billion INR | 64.071% |
| NATCO Pharma Limited | 25.73 Billion INR | 34.725% |
| Suven Life Sciences Limited | -200.79 Million INR | 8466.3% |
| Krebs Biochemicals & Industries Limited | -108.74 Million INR | 15548.04% |
| Strides Pharma Science Limited | 14.38 Billion INR | -16.758% |
| Indoco Remedies Limited | 8.04 Billion INR | -108.868% |
| Alpa Laboratories Limited | 188.89 Million INR | -8793.449% |
| Lasa Supergenerics Limited | 121.02 Million INR | -13780.261% |
| Sun Pharma Advanced Research Company Limited | 391.06 Million INR | -4195.766% |